The British government has gotten involved in a lawsuit against 3M over how it managed a technology it acquired from a company partially owned by a U.K. Ministry of Defence subsidiary. Four years ago, 3M bought a potential breakthrough device from Acolyte, a U.K. company owned by the Porton Group and a subsidiary of the […]
A British company is alleging that diversified conglomerate 3M Co. sabotaged a device that it sold to the St. Paul, Minnesota company in favor of bringing 3M’s own, more expensive solution to the market. Five years ago, the Porton Group sold 3M a potential breakthrough device called the BacLite, which uses a special fluorescent light […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Andover Healthcare Inc. pulls its compression bandage system off the market in the face of a legal move by 3M Co. to enforce a recently won patent. 3M Co. (NYSE:MMM) forced a compression bandage system made by Andover Healthcare Inc. off the market by threatening to seek a legal injunction barring sales of the product. […]
3M Cos. (NYSE: MMM) said Thursday it will pay $810 million to purchase Arizant Inc. in Eden Prairie, Minnesota, a maker of products that help keep patients warm in hospitals, especially during surgeries. One person who's probably paying special attention to the deal is Scott Augustine, the former CEO of Arizant.
Aside from sharing the same first letter, “mojo” and “Minnesota” are words that don’t seem to carry a lot in common, though that may soon change. The state is home to 19 Fortune 500 companies, a world-class hospital and research center in Rochester and SPAM–what else do you need? But the land of 10,000 lakes […]
A top Commerce Department official Tuesday vowed to unclog the country’s beleaguered patent office, linking efforts to clear hundreds of thousands of patent applications to creating jobs and reducing America’s trade deficit. In an interview with MedCity News, David Kappos, Undersecretary of Commerce for Intellectual Property who directs the United States Patent and Trademark Office […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
This is the second major divestiture for AMS in the past six months. The Minnetonka-based company sold its Ovion sterilization technology to Mountain View, Calif.-based Conceptus Inc. for $23.6 million last October.